Frazier LifeSciences Acquisition Corporation
Blank-check company (SPAC) sponsored by Frazier Life Sciences that raised capital to merge with a biopharmaceutical company; combined with NewAmsterdam Pharma in 2022.
Frazier LifeSciences Acquisition Corporation was founded in 2020, is headquartered in Seattle, has 1 recorded investment, and includes 1 company in its recorded portfolio.
- Headquarters
- Seattle
- Founded
- 2020
- AUM
- $100.0M
- Portfolio Company
- 1
- Total Investment
- 1
- Last Investment
- Feb 2024
- Geographic Focus
- United States
Indexed holds 1 portfolio company and 1 funding round for this investor. The full record is or through the API.
Investment Thesis
Frazier LifeSciences Acquisition Corporation is a Venture Capital firm based in Seattle. It was founded in 2020. It has made 1 investment, including NewAmsterdam Pharma. Focus areas include Biotech.
Portfolio1
Co-investors4
Sign up to view co-investors
4 co-investors across 4 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×3 · Private Equity ×1
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/frazier-lifesciences-acquisition-corporation"><img src="https://indexed.vc/api/badge/investor/frazier-lifesciences-acquisition-corporation" alt="Frazier LifeSciences Acquisition Corporation on Indexed.vc" width="260" height="76" /></a>